Skip to content
10-Q

Quarterly Report

Tevogen Bio Holdings Inc. TVGN TVGNW

0001641172-25-010395

← back to feed
Filed
May 14, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 13, 2025 183.89M sh
Current Liabilities Q1 2025 · Mar 31, 2025 $8.72M
Current Liabilities Q1 2025 · Dec 31, 2024 $9.04M
Total Liabilities Q1 2025 · Mar 31, 2025 $11.79M
Total Liabilities Q1 2025 · Dec 31, 2024 $10.14M
Current Assets Q1 2025 · Mar 31, 2025 $3.08M
Current Assets Q1 2025 · Dec 31, 2024 $2.36M
Total Assets Q1 2025 · Mar 31, 2025 $4.07M
Total Assets Q1 2025 · Dec 31, 2024 $3.46M
Shares Diluted Q1 2025 · Mar 31, 2024 142.39M sh
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$2.16M
Stockholders Equity Q1 2025 · Mar 31, 2024 −$5.8M
Stockholders Equity Q1 2025 · Dec 31, 2023 −$94.43M
Eps Diluted Q1 2025 · Mar 31, 2024 −$0.26
Eps Basic Q1 2025 · Mar 31, 2024 $0.08
Sga Expense Q1 2025 · Mar 31, 2024 $8.71M
Rd Expense Q1 2025 · Mar 31, 2024 $20.81M
Net Income Q1 2025 · Mar 31, 2024 $11.26M
Operating Income Q1 2025 · Mar 31, 2024 −$29.52M